Keyphrases
Phosphorylation
100%
Neurotoxicity
100%
Huntingtin
100%
Cyclin-dependent Kinase Inhibitor
100%
Roscovitine
100%
Huntington's Disease
75%
Cyclin-dependent Kinase 5 (Cdk5)
50%
Post-translational Modification Sites
37%
Protein Toxicity
25%
Methylation
12%
Brain Regions
12%
Mouse Brain
12%
Protective Effect
12%
Therapeutic Strategies
12%
Autosomal Dominant
12%
Mutated Genes
12%
Acetylation
12%
Kinase Inhibitor
12%
Neurodegenerative Diseases
12%
CAG Trinucleotide Repeat
12%
Neurodegeneration
12%
Striatum
12%
Knockdown
12%
Single-point mutation
12%
Mutant Huntingtin
12%
Disease Treatment
12%
SUMOylation
12%
Cyclin-dependent Kinase
12%
Large Proteins
12%
CAG Repeat
12%
Serine Phosphorylation
12%
Cyclin-dependent Kinase 1 (CDK1)
12%
In Vitro Kinase Assay
12%
Gene mutant
12%
IP Injection
12%
Neuroscience
In Vitro
100%
Huntingtin
100%
Seliciclib
100%
Cyclin-Dependent Kinase
100%
Huntington's Disease
42%
Serine
21%
Posttranslational Modification
21%
Kinase
14%
In Vivo
7%
Striatum
7%
Neurodegenerative Disorder
7%
Trinucleotide Repeat
7%
CAG Repeat
7%
Neurodegeneration
7%
Amino Terminal Sequence
7%
Acetylation
7%
Sumoylation
7%
Methylation
7%
Mouse Brain
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclin Dependent Kinase Inhibitor
100%
Roscovitine
100%
Huntingtin
100%
Huntington Chorea
42%
Serine
21%
Phosphotransferase Inhibitor
7%
Combination Therapy
7%
Trinucleotide
7%
Nerve Degeneration
7%
Phosphotransferase
7%
Degenerative Disease
7%
Cyclin Dependent Kinase
7%